Description
• Exhibits potent broad spectrum of antibacterial activity, coverage of B-lactamase-producing pathogens and a favourable pharmacokinetic/pharmacodynamic profile.
• Clavulanic acid renders most B-lactamase-producing isolates susceptible to Amoxycillin.
• Amoxicillin/Clavulanic acid is clinically and bacteriologically superior to Amoxicillin alone against different organisms.
• Combination of Clavulanic acid and Amoxicillin is highly effective in the treatment of UTIs caused by penicillin-resistant bacteria.
Community Acquired Pneumonia
Chronic Bronchitis
Urinary Tract Infections
Intra-abdominal Infections
Skin & Soft Tissue Infection
Surgical Prophylaxis
Lxir Medilabs is more than just a PCD Pharma Franchise Company; we’re your partner in success. We offer a diverse portfolio of over 300+ high-quality, affordable medicines catering to various therapeutic segments. Backed by WHO-GMP certification and a dedicated R&D team, we consistently deliver innovative formulations that meet the evolving needs of the healthcare industry.
Fill out the form below to express your interest in becoming a PCD Pharma Franchise Partner with Lxir Medilabs. Our team will be in touch shortly to discuss your specific requirements and guide you through the next steps.
Don’t wait! Take the first step towards a successful future in PCD Pharma franchising. Contact Lxir Medilabs today!
